Skip to content
dextropropoxyphene

Structure via PubChem · Public domain (PubChem)

EntityQ2268608· pop 24· linked from 2,184 articles

dextropropoxyphene

Sign in to save

Also known as (+)-alpha-propoxyphene, Darvon®, propoxyphene, d-Propoxyphene, alpha-D-4-Dimethylamino-3-methyl-1,2-diphenyl-2-butanol-propionat, alpha-(+)-4-Dimethylamino-1,2-diphenyl-3-methyl-2-butanol propionate ester, Dextropropoxyphen, Destropropossifene

Dextropropoxyphene is an opioid analgesic patented in 1955 and manufactured by Eli Lilly and Company. It is an optical isomer of levopropoxyphene. It is intended to treat mild pain and also has antitussive (cough suppressant) and local anesthetic effects. The drug has been taken off the market in Europe and the United States due to concerns of fatal overdoses and heart arrhythmias. It is still available in Australia, albeit with restrictions after an application by its manufacturer to review its proposed banning. Its onset of analgesia (pain relief) is said to be 20–30 minutes and peak effects

Key facts

Drug.Verifiedfields
changed
Drug.Watchedfields
changed
Drug.class
Opioid
Drug.verifiedrevid
460780758
Drug.IUPAC_name
(1S,2R)-1-benzyl-3-(dimethylamino)-2-methyl-1-phenylpropyl propionate
Drug.image
Dextropropoxyphene structure.svg
Drug.image_class
skin-invert-image
Drug.width
200px
Drug.image2
Dextropropoxyphene3DanJ.gif
Drug.image_class2
bg-transparent
Drug.width2
200px
Drug.tradename
Darvon, Darvocet
Drug.MedlinePlus
a682325
Drug.licence_US
Propoxyphene
Drug.pregnancy_AU
C
Drug.legal_AU
S4
Drug.legal_BR
A2
Drug.legal_CA
Schedule I

via Wikipedia infobox

Chemical data

Formula
C22H29NO2
Molecular weight
339.5 g/mol
IUPAC name
[(2S,3R)-4-(dimethylamino)-3-methyl-1,2-diphenylbutan-2-yl] propanoate
SMILES
CCC(=O)O[C@](CC1=CC=CC=C1)(C2=CC=CC=C2)[C@H](C)CN(C)C
InChIKey
XLMALTXPSGQGBX-GCJKJVERSA-N
XLogP
4.2
Polar surface area
29.5 Ų
H-bond donors
0
H-bond acceptors
3
Formal charge
0

via PubChem

Research

1,965 papers

via PubMed

Wikidata facts

Mass
339.219829
Show 6 more facts
isomeric SMILES
CCC(=O)O[C@@](CC1=CC=CC=C1)([C@H](C)CN(C)C)C2=CC=CC=C2
chemical formula
C₂₂H₂₉NO₂
canonical SMILES
CCC(=O)OC(CC1=CC=CC=C1)(C2=CC=CC=C2)C(C)CN(C)C
NCI Thesaurus ID
C61912
World Health Organisation international non-proprietary name
dextropropoxyphene
Commons category
Dextropropoxyphene
Sources (5)

via Wikidata · CC0

~17 min read

Article

25 sections
Contents
  • Medical uses
  • Analgesia
  • Restless legs syndrome
  • Available forms
  • Contraindications
  • Side effects
  • Pharmacology
  • Toxicity
  • History
  • Use in organic synthesis
  • Society and culture
  • Usage controversy and regulation
  • Australia
  • Canada
  • European Union
  • New Zealand
  • India
  • Sweden
  • United Kingdom
  • United States
  • In media
  • Use by right-to-die societies
  • Drug testing
  • See also
  • References

Dextropropoxyphene is an opioid analgesic patented in 1955 and manufactured by Eli Lilly and Company. It is an optical isomer of levopropoxyphene. It is intended to treat mild pain and also has antitussive (cough suppressant) and local anesthetic effects. The drug has been taken off the market in Europe and the United States due to concerns of fatal overdoses and heart arrhythmias. It is still available in Australia, albeit with restrictions after an application by its manufacturer to review its proposed banning. Its onset of analgesia (pain relief) is said to be 20–30 minutes and peak effects are seen about 1.5–2.0 hours after oral administration.

Dextropropoxyphene is sometimes combined with paracetamol (acetaminophen). Trade names include Darvocet-N, Di-Gesic, and Darvon with APAP (for dextropropoxyphene and paracetamol). The British approved name (i.e. the generic name of the active ingredient) of the paracetamol/dextropropoxyphene preparation is co-proxamol (sold under a variety of brand names); however, it has been withdrawn since 2007, and is no longer available to new patients, with exceptions. The paracetamol combinations are known as Capadex or Di-Gesic in Australia, Lentogesic in South Africa, and Di-Antalvic in France (unlike co-proxamol, which is an approved name, these are all brand names).

Gallery (5)

Connections

Categories